Showing results (11-20 of 21) with videos related to
Sort By:
Pageof 3
Eukaryotic Cell|September 30, 2008
Changes in the N-glycome, glycoproteins with Asn-linked glycans, of Giardia lamblia with differentiation from trophozoites to cystsDaniel M Ratner, Jike Cui, Martin Steffen, et al.Proceedings of the National Academy of Sciences of the United States of America|January 25, 2005
The diversity of dolichol-linked precursors to Asn-linked glycans likely results from secondary loss of sets of glycosyltransferasesJohn Samuelson, Sulagna Banerjee, Paula Magnelli, et al.Proceedings of the National Academy of Sciences of the United States of America|July 4, 2007
The evolution of N-glycan-dependent endoplasmic reticulum quality control factors for glycoprotein folding and degradationSulagna Banerjee, Prashanth Vishwanath, Jike Cui, et al.Glycobiology|March 24, 2010
Molecular characterization of the cis-prenyltransferase of Giardia lambliaKariona A Grabińska, Jike Cui, Aparajita Chatterjee, et al.Molecular and Biochemical Parasitology|April 20, 2006
The cyst wall of Entamoeba invadens contains chitosan (deacetylated chitin)Suchismita Das, Katrina Van Dellen, Dorota Bulik, et al.Eukaryotic Cell|June 17, 2008
Dolichyl-phosphate-glucose is used to make O-glycans on glycoproteins of Trichomonas vaginalisKariona A Grabińska, Sudip K Ghosh, Ziqiang Guan, et al.The Journal of Biological Chemistry|April 18, 2008
Unique Asn-linked oligosaccharides of the human pathogen Entamoeba histolyticaPaula Magnelli, John F Cipollo, Daniel M Ratner, et al.Eukaryotic Cell|September 21, 2010
The antiretroviral lectin cyanovirin-N targets well-known and novel targets on the surface of Entamoeba histolytica trophozoitesAndrea Carpentieri, Daniel M Ratner, Sudip K Ghosh, et al.Eukaryotic Cell|September 29, 2009
Suggestive evidence for Darwinian Selection against asparagine-linked glycans of Plasmodium falciparum and Toxoplasma gondiiG Guy Bushkin, Daniel M Ratner, Jike Cui, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 7, 2023
MANIFEST: Pelabresib in Combination With Ruxolitinib for Janus Kinase Inhibitor Treatment-Naïve MyelofibrosisJohn Mascarenhas, Marina Kremyanskaya, Andrea Patriarca, et al.Pageof 3